Long-term survival of patients treated with octreotide for metastatic well differentiated neuroendocrine carcinoma of the lung

Journal of Cardiovascular Surgery

Volumn 41, Issue 5, 2000, Pages 773-776

  Filosso, P L ^a   Croce, S ^a   Oliaro, A ^a   Ruffini, E ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Lung neoplasms; Lung, neuroendocrine carcinoma; Neoplasms metastasis; Neuroendocrine tumors; Octreotide, therapeutic use

Indexed keywords

OCTREOTIDE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER INHIBITION; CANCER SURVIVAL; CARCINOID SYNDROME; CASE REPORT; DRUG INDICATION; FEMALE; HUMAN; ILLNESS BEHAVIOR; LUNG CARCINOMA; MALE; METASTASIS; PARANEOPLASTIC SYNDROME; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, NEUROENDOCRINE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCTREOTIDE;

EID: 0034529527     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Atypical carcinoid tumors of the lung
2. Neuroendocrine neoplasm of the broncho-pulmonary tract
3. Changing times and surgical management of broncho-pulmonary carcinoid tumor
4. Cacinoid tumors of the lung: Do atypical features require aggessive management?
5. Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide
6. Clinical efficacy of octreotide in the treatment of metastic neuroendocrine tumors
7. 111In-DTPA-Phe-octreotide scintigraphy in neuroendocrine tumors correlate with reponsiveness to somatostatin analogue treatment
8. The value of octreotide scintigraphy in patients with lung cancer
9. 123I-Tyr) octreotide: The Rotterdam experience with more than 1000 patients